Angiotensin-converting enzyme inhibitors (ACE) and angiotensin II receptor blockers (ARB) have been among the first-line medications in the treatment of patients with hypertension (HTN), diabetes mellitus (DM), and heart disease [1]. This evidence concerns the gene ACE and Hypertension.